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ANALYSIS OF THE BIOLOGICAL ROLE OF THE PRION RELATED SHADOO 
PROTEIN ON EARLY MOUSE EMBRYOGENESIS 
 
 
Summary 1- 
The prion family comprises of Prion, Shadoo and Doppel proteins, encoded by Prnp, Sprn 
and Prnd, respectively.Expression pattern of these genes in early mouse embryogenesis was 
investigated using RT-PCR experiments on FVB/N mice embryosand by in situ hybridization 
(HIS) at 3 early developmental stages.  They were found to be expressed at all stages, in both 
placenta and embryo.Ubiquitous hybridization was observed for the three lociby HIS. These 
results are compatible with potential biological overlapping roles of these proteins during 
mouse embryogenesis.  
We also analyzed the transmission of an LS1.06 transgenic mice line, characterized by a 70% 
downregulationofSprngene expression.Only 5% of offspring from FVB/N LSI.06
+/-
-Prnp
+/-
with FVB/N Prnp
-/-
crosses were of a FVB/N LSI.06
+/-
-Prnp
-/-
 genotype, suggestive ofa lethal-
associated embryonic phenotype. However, crossing FVB/N LSI.06
+/-
-Prnp
-/-
with Prnp
-/-
 
showed a Mendelian transmission rate. This suggested a physical linkage between the 
transgene integration site and Prnp locus. Indeed, the transgene integration site was found to 
be located within an intron of the mouse Api5 gene, at 37.5 Mbof thePrnp locus. It thus likely 
explains the observed transmission rates. 
 
Keywords- Prion-family, Shadoo, Transgenesis, Mouse, Embryogenesis 
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Summary 2- 
Prions are infectious proteinaceous particles responsible for transmissible spongiform 
encephalopathies (TSE).The pathology and clinical disease associated with TSE are brought 
about by conversion of the cellular form of prion proteinPrP
C
, encoded by Prnp, to an 
infectious isoformPrP
Sc
. Along with PrP
c
, two other structurally-related proteins, called 
Doppel and Shadoo, encoded by Prnd and Sprn, havebeen identified as its paralogs. These 
three genes constitute ‘the prion family’. However, the biological roles and possible 
biological redundancy between these proteins remain mostly enigmatic although a potential 
involvement during early embryogenesis was suggested. The first aim of my study was to 
investigate the expression pattern of the Prion gene family in early mouse embryogenesis to 
look for potential overlaps between them and to assess their putative role. Expression analysis 
of the three genes was done by RT-PCR experiments on FVB/N andFVB/N Prnp
-/-
embryosand by in situ hybridization (HIS) at three developmental stages. RT-PCR 
experiments showed lower expression pattern of Prnd and Sprncompared toPrnp. Expression 
was observed in all studied stages, in both placenta and embryo, except in Prnp
-/-
 for 
Prnp.Ubiquitous hybridization was observed for the three lociby HIS.These results are 
compatible with potential biological overlapping roles and expression of these proteinsand 
also point out a potential role of Doppel in early embryonic stages. It would be of interest to 
assess the phenotypic consequences of the invalidation of Sprn and Prnd, and of the three 
loci. Comparative histological analysis was done between E7.5 FVB/N and FVB/N Prnp
-/-
 
mouse embryos. The phenotype was similar except for the observation of hemorrhagic foci in 
front of ectoplacental cone in FVB/N.This could be due to the involvement of PrP
C
 in 
biological pathways like angiogenesis, inflammation and cell mobility. 
The second aim of my study was the analysis ofthe LSI.06 transgenic line and of 
thetransmission of its transgene onto Prnp
-/-
genetic backgrounds. This line expresses 
ubiquitously a ShRNA against Sprn and has 70% downregulation of Sprn expression as 
observed in the adult brain. Transmission studies weredone by crossing FVB/N LSI.06
+/-
-
Prnp
+/-
 with Prnp
-/-
 mice. FVB/N LSI.06
+/-
-Prnp
-/-
and LSI.06
-/-
-Prnp
+/-
offsprings were less 
than 5% and 16%, respectively. LSI.06
+/-
-Prnp
+/-
 mice were also crossed with C57/129/Sv 
Prnp
-/-
animals to analyze the incidence of the genetic background associated with Prnp
-/-
. 
There was again a non-Mendelian transmission with deficiency in LSI.06
+/-
-Prnp
-/-
 and 
LSI.06
-/-
-Prnp
+/-
 offsprings.FVB/N LSI.06
+/-
-Prnp
-/-
were crossed with FVB/N Prnp
-/-
 mice to 
analyze secondary transmission rate of the LSI.O6 transgene. It showed a Mendelian 
[3] 
 
transmission rate. This data suggested a physical linkage between theLSI.06 transgene 
integration site and thePrnp locus rather than a lethal-associated embryonic phenotype. 
However, assessment of the fecundity of such mice, including growth rate and robustness of 
pups might give us a possible clue for what are the further effects of such introgression.The 
transgene integration site was cloned and found to be located within the last intron of the ORF 
of the mouse Api5 (apoptosis inhibitor 5) gene,at 37.5 Mbof thePrnp locus. It thus likely 
explains the observed transmission rates. 
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INTRODUCTION 
 
1. The Prion: a non-conventional transmissible agent 
 
Prions are highly infectious particles which are composed entirely of protein and lack nucleic 
acid, making them different from other infectious agents. In humans and in animals they are 
responsible for a range of neurodegenerative diseases collectively called as transmissible 
spongiform encephalopathies (TSE’s). However,the role of prions in TSE’s remained 
unidentifiedfor a long time. The agent responsible for TSE’s was initially considered to be a 
slow virus (Sigurdsson 1954).  Later it was proposed that it lacks nucleic acid, besides being 
too small in size to be a virus (Alper et al., 1966). Also the agent was found to be inactivated 
by treatment with phenol, urea, proteinase K (i.e. the procedures that inactivate proteins) and 
was stable or resistant to UV irradiation, treatment with nucleases, divalent cation hydrolysis, 
heat inactivation(i.e. the procedures that intervene nucleic acids). Thus, this ‘viral hypothesis’ 
could not be proved. Subsequently in 1982, the term ‘Prion’ was coined by Prusiner and 
‘Protein only’ hypothesis was accepted much later with much debate and attempts to 
disapprove it (Prusiner 1982, 1998) In animals TSE’s include scrapie in sheep, which has 
been prevalent in Europe for more than 200 years and is also recognized in countries 
worldwide. Other important diseases are transmissible mink encephalopathy, chronic wasting 
disease of mule deer and elk, bovine spongiform encephalopathy (BSE), feline spongiform 
encephalopathy in domestic cat, exotic ungulate encephalopathy.  Human Prion diseases 
comprise of Creutzfeldt-Jakob disease (CJD) which includes iatrogenic CJD, variant CJD, 
probably arising from BSE-contaminated food, familial CJD, and sporadic CJD. Other human 
prion diseases are Gerstmann Straussler Sheinker disease, fatal familial insomnia, fatal 
sporadic insomnia syndrome and Kuru.  
 
All these diseases are of genetic, sporadic (via spontaneous mutations or due to higher genetic 
susceptibility to the infection) or infectious origins (via ingestion of prion contaminated food, 
scarred skin or iatrogenic). These infections typically remain asymptomatic for years, with the 
disease being always progressive and fatal once the clinical signs develop (Prusiner, 1998). 
The diseases are characterized commonly by neurological symptoms like ataxia in animals 
and progressive dementia in human commonly (Wells et al., 1987). 
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The histopathological description includes spongiform vacuolization of brain grey matter, 
neuronal loss, astrogliosis, and accumulation of amyloid plaques, which is common to both 
animal and human conditions (Collinge, 2001). These abnormal changes are brought about by 
post translational conversion of cellular form of prion protein (PrP
C
) to an infectious isoform 
called PrP
Sc
.Abnormal isoform of PrP, i.e. PrP
Sc
,has higher proportion of β sheets rather than 
α helical coiled sheets,that is normally present in PrPC specially in the region between residues 
90 and 140, leading to aggregations in the form amyloid fibres and plaques (Huang et al., 
1996, Prusiner, 1998). 
 
The mechanism of conversion of PrP
C
 to PrP
Sc
 is incompletely understood. Amongst the 
several mechanisms proposed, one called ‘heterodimer mechanism’ elucidates that PrPScacts 
as a template to guide or catalyse the conversion and misfolding of PrP
C
 to PrP
Sc
 (Cohen et 
al., 1994). The second proposition states that a mixed aggregation of PrP
C
 and PrP
Sc 
leads to 
an auto catalytic self propagation of PrP
Sc.
(Bieschkeet al.,2004).Another mechanism for the 
replication of prions is the nucleation-polymerisation model. According to this, PrP
Sc 
is 
actually a polymorphic form ofmonomeric PrP
C
. Monomeric form of prion protein 
polymerizes to oligomers forming an unstable nucleus. This process remains at an equilibrium 
until a critical concentration of monomers is outreached. Following this event, along with 
addition of an ‘infectious seed’, another monomeric prion protein unit amplifies the 
polymerisation process leading to stable aggregates and amyloid plaques in brain (Harper & 
Lansbury 1997). 
 
The exact nature of the neurotoxicity associated with PrP
Sc
 remains poorly understood. Mice 
lacking PrP
C
 expression in their entire body or only in their brain demonstrate no neuro-
degeneration even in the presence of exogenous PrP
Sc
, indicating an absolute requirement of 
PrP
C
 for pathological lesions associated with the prion diseases (Bueler et al., 1993, Brandner 
et al., 1996). Similarly, neuronal PrP
C
 depletion in adult TSE-inoculated mice induces the 
disappearance of the clinical signs and a partial recovery despite accumulation of large 
amount of PrP
Sc
 and of infectivity (Mallucci et al., 2002), highlighting the specific neuronal 
PrP
C
 involvement in the pathology.  Moreover, accumulation of atypical PrP
Sc
 and little 
clinical manifestation of the disease were shown in mice expressing relatively moderate levels 
of PrP
C
 without GPI anchor rather than the normal PrP
C
 with GPI anchor (Chesebro et al., 
2005). At moderate expression levels, scrapie infection induced a new fatal disease with 
unique clinical signs and altered neuropathology in these PrP-anchorless expressing 
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transgenic mice (Chesebro et al.,2010). At even higher levels of expression, transgenic mice 
expressing anchorless-PrP develop spontaneous neurologic dysfunction characterized by 
widespread amyloid deposition in the brain (Stohr et al., 2011). Thus, both the cellular 
location of PrP and its expression level appears to influence its potentiality to sustain or 
induce neuropathologies.  
 
2. The biological functionof PrP remains enigmatic 
 
Despite its well documented involvement in spongiform encephalopathies, the biological role 
of PrP
C
 remains mostly unknown.PrP
C
 is coded by a conserved gene Prnp in mammals, birds, 
fish and has also been identified in Xenopus laevis (Aguzzi and Calella, 2009). Located on 
chromosome 20 in humans and chromosome 2 in mice, it is normally expressed on the cell 
membranes throughout the body and at higher levels in neurons, lymphocytes (Cashman et 
al,. 1990) and stromal cells of lymphoid organs (Kitomotoet al., 1991). One difficulty for 
deciphering the biological function of PrP comes from the observation that the Prnp(Prnp
-/-
) 
knockout mice live normally and don’t exhibit any immunological defects (Bueler et al., 
1992). Knockout cattle and goat were similarly obtained with no obvious associated 
phenotype. Careful phenotyping of the knockout mice revealed some subtle neuronal 
alterations. Amongst the many subtle defects in PrP null mice is disruption of calcium and 
potassium ion channel in hippocampus (Collinge et al., 1996). Additionally, mice post natally 
ablated for prion protein are found to be having electrophysiological defects like decreased in 
after hyperpolarization in hippocampal CA1 cells (Mallucci et al., 2002). PrP
C
 knockout mice 
have also been shown to exhibit an altered circadian rhythm. The behavioral change in fatal 
familial insomnia might indicate that PrP
C
 has a possible role in maintaining normal circadian 
rhythm (Tobler et al., 1996).However, while PrP
C
 was reported to aid a normal synaptic 
transmission (Collinge et al., 1994), Prnp null mouse have normal synaptic transmission in 
CA1 hippocampal region (Lledo et al., 1996).  
 
PrP
C
 appears to be involved in adult mammalian neural development and neurogenesis in 
dentate gyrus and olfactory bulb. But other factors are also involved in neurogenesis, since 
regardless of expression of PrP
C
 the final number of neurons in the dentate gyrus remained the 
same (Steele et al., 2005). Lethal irradiation of PrP knockout mice impaired the self renewal 
of haemopoetic stem cells and made them more sensitive to depletion following the treatment 
with cell cycle specific myelotoxic agent. Exogenous expression of PrP
C
 through reteroviral 
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infection rescued this effect (Zhang et al., 2005). This and other data suggest a role of PrP in 
stem cell biology (Lopes and Santos, 2012). However, its precise role remains uncertain and 
appears to differ between the tissue and/or the species origin of the stem cells. It has been 
shown that PrP
C
 is involved in the transduction of specific signals via for example the  
activation of the tyrosine kinase Fyn (Mouillet-Richard et al., 2000) and the negative 
regulation of the signaling activity of β1 integrins (Loubet et al., 2012), both involved in 
neuritogenesis. 
 
PrP
C
 has also neuroprotective properties. In human neurons, PrP
C
 counteracts Bax induced 
cell apoptosis. Provided surface localization of PrP
C
 and its transport are adequate, this anti-
apoptic activity of PrP
C
 is retained in its secretory form (i.e. PrP
C
 lacking GPI anchor).  
Moreover, following a cerebral hypoxia and ischemia in humans and in rodents, PrP
C
 
expression is up-regulated. In case of induced cerebral hypoxia, the PrP null mice had a 
greater infarct size, while in case of induced ischemic damage the severity of ischemia affects 
the amount of PrP up-regulation, consequently the severity of lesion and neuronal damage. 
(McLennan et al., 2004, Weise et al.,2004). This ischemic injury was later found out to be 
decreased on over expression of PrP
C
 by adenovirus mediated gene targeting (Shyu et al., 
2005). It indicates an important protective action of PrP
C
 and its possible involvement in 
stroke biology. 
 
A role of PrP
C
 in the modulation of the calcium dependent embryonic cell adhesion and of 
efficient gastrulation has been demonstrated in zebrafish (Malaga-Trillo et al.,2009). 
Transcriptomic alteration during early embryogenesis in PrP null mice highlighted similar 
biological pathways, although with no adverse visible phenotype (Khalife et al., 2011). The 
possible role of PrP
C
 during embryogenesis, suggested by its developmental regulation 
(Tremblay et al., 2007, Miele et al., 2003), is perhaps a clue to why Prnp is a evolutionary 
conserved gene  
 
To explain how a protein such as PrP is evolutionary conserved, putatively implicated in 
embryogenesis and neuritogenesis, is neuroprotective while PrP
Sc
 is neurotoxic, and that Prnp 
genetic invalidation has little phenotypic consequences in mammals, it was hypothesized that  
[8] 
 
 
Figure 1.The LPrP model of functional interactions between prion proteins in transgenic 
mice. (a) In wild-type (Prnp+/+) mice, initiation of unidentified signaling event following 
PrP
c
 binding (in cis or trans configuration) to a hypothetical ligand (LPrP) favours cell 
survival. A C-terminal anchoring site and an N-terminal effectors’ site are the two implicated 
binding sites of PrP
C
 for LPrP which enable signaling. (b)π , a hypothetical PrPC-like protein 
shares common N-terminal effectors’ domain with PrPC thar binds to LPrP initiating the 
favorable signaling event in the absence of PrP
C
 in Prnp
0/0 
mice. (c) Since N terminal 
effectors’ domain is required for pro-survival signaling, following Doppel or ΔPrP binding to 
LPrP in Prnp
0/0 mice initiates ‘improper’ signaling leading to cellular death. (d) PrPC 
possesses higher affinity for LPrP which reduces Doppel/ΔPrP binding in Prnp+/+ mice (This 
figure was taken from Shmerling et al., 1998) 
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another host-encoded protein, called π, can bind to a putative PrP-receptor at the cell 
membrane and induces similar transducing pathways in the absence of PrP (Figure 1, 
Shmerling et al.,1998).    
 
3. PrP belongs to a gene family.      
 
The prion gene phylo-genetically derives from a ZIP-like ancestral molecule of metal ion 
transporters (Schmitt-Ulms et al., 2009). Besides PrP
C
, two other closely structurally-related 
proteins called Doppel and Shadoo have been identified as its paralogs comprising what is 
called the ‘prion gene family’. The biological functions of these two proteins and their 
interactions remain equally elusive. Like PrP
C
, both Doppel and Shadoo are GPI anchored 
proteins.  
 
Comparable to PrP
C
, Doppel has 3 α helices, shares 24% sequence identity and has a similar 
C terminal domain to that of PrP
C
. In contrast, Shadoo has a similar N terminal half and 
hydrophobic tract to that of PrP
C
. Both the proteins lack octarepeat regions.(Figure 2, Watts 
and Westaway 2007) 
 
Doppel which is encoded by the gene Prnd is located 16 kb dowstream to Prnp. In adult male 
humans, rodents, and boars it is mainly expressed in testis, ejaculated spermatozoa, seminal 
plasma, semeniferous tubules, sertoli cells, with there being a variation in level of expression. 
Also during embrygenesis and neonatal life it is reported to be expressed at low levels in brain 
and circulating lymphoid cells, B cells, neutrophils and in follicular dendritic cells. (Moore et 
al., 1999, Serres et al., 2006)  
 
Doppel is important for maintaining male fertility. Prnd
-/-
 and Prnd
-/-
- Prnp
-/-
 double knockout 
mice both develop normally, but, due to an absence of acrosome reaction, their 
spermatozoides are incapable of fertilizing oocytes noramally in vivo. At a decreased rate in 
vitro fertilization could the carried out. There is an elevation in the oxidative DNA damage of 
spermatozoa (Paisley et al., 2004) The importance of Doppel for the maintenance of fertility 
was confirmed by another group as well in which the Prnd null mice had low number of 
spermatoza, were morphologically abnormal and immotile (Behrens et al., 2002).  
Due to its stuctural similarity and close distance from Prnp gene, it could appear logical to 
assume that Doppel, along with PrP
C
, is also involved in TSE pathogenesis. However, in a 
[10] 
 
 
Figure 2.Schematic representation of the domain architecture of the prion protein family 
members. Doppel and PrP
C
 have structured C-terminal domains consistingof 3 α-helices and 2 
short β-strands and basically-charged N-terminal regions. Disulfide bridges are indicated 
above the proteins (–S–S–) and N-glycosylationsites (CHO) are denoted below the proteins. 
PrP
C
and Shadoo share a common hydrophobic tract. PrP has octarepeats that can bind copper, 
while Shadoo arginine and glycine richtetrarepeats (This figure was taken from Watts & 
Westaway 2007). 
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mice affected by TSE the PrP
Sc
 mass and dissemination, incubation period along with extent 
of vacuolization is not affected by the degree of expression of Prnd in the CNS, nor does this 
degree of expression of Prndhas been shown to have any impact on the course and 
pathogenesis of TSE (Tuzi et al., 2002). This has been found to hold true in case of CJD 
patients too, where the disease pathogenesis is unaffected by the presence or absence of 
Doppel expression (Peoc’h et al., 2003). 
 
Doppel was also shown to be neurotoxic causing neurodegeneration. Although normally 
Doppel was shown to be expressed in low amounts in adult brain, its expression gets up-
regulated in some PrP
C
 null mice leading to development of late onset ataxia and purkinje cell 
loss (Moore et al., 1999). It has been demonstrated that the higher the expression of Doppel is 
in the brain, higher is the extent of purkinje cell loss and earlier is the onset of ataxia (Rossi et 
al., 2001). Interestingly, this Doppel induced neurotoxicity could be rescued by PrP
C
 
(Masterangelo and Westaway, 2001).  
 
The gene encoding the second PrP
C
 paralog Shadoo is on chromosome 7 in mice. It is 
expressed in adult CNS in rodents, sheep, bovines and humans. However the degree and exact 
location might vary between the species (Daude and Westaway 2011). It has also been shown 
to be expressed in testicle and ovary in mice (Young et al., 2011). Interestingly, Shadoo’s 
(Sho) expression is higher in dendrites than in cerebellar granular neurons which is exactly 
the contrary to PrP
C
 suggesting of functional redundancy. Sho also shows functional overlaps 
and share common protein binding partners with PrP
C
. Amongst these common functions is 
the neuroprotective properties against Doppel and N terminal truncated PrP
C
 (Figure 3, Watts 
et al., 2007). Sho has further been displayed to be down regulated in disease specific manner 
during TSE and accumulation of PrP
Sc
 in CNS, pointing towards the fact that it might act as a 
stand by substrate for PrP
Sc
. Additionally α-Sho antibodies generated against Sho could be 
used as a tool to measure it’s expression and serve as a diagnostic tool earlier in the course of 
disease (Westaway et al., 2011).  
 
Knockdown of Sprn gene expression by RNA interference using lentivirus vectors revealed 
early embryonic lethality in FVB/N PrP
-/-
  but not in FVB/N mice suggesting that either PrP 
or Sho is required for normal mouse early development (Young et al., 2009). Furthermore, 
origin of this lethality could be correlated with a failure of the trophoectoderm cell lineage by  
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Figure 3.Reduced Sho levels in clinically ill prion-infected mice. (A) Western blot of 
homogenates prepared from the brains of non-inoculatedor clinically ill (average of 172 days 
post-inoculation) RML prion-inoculated mice (C3H/C57BL6 background). Remarkable 
reduction of Sho protein levels in prion-infected brains. For comparison purpose levels of the 
GPI-anchored protein Thy-1 are shown. (B) Quantitation of Sho(06rSH-1) and Thy-1 blot 
signals in panel A by densitometry. Sho levels in prion-infected brains are reducedto 
12.172.8% (Po0.001) the levels observed in non-inoculated mice. ***P<0.001. (C) Western 
blot analysis to assessexpression of neuronal markers in prion-infected andcontrol mouse 
brains. In prion-infected brains, neuron-specific enolase (NSE) or calbindin levels are 
unchanged, and synaptophysin levels are decreased moderately. (D) Brain homogenates of 
clinically ill (8 months old) Tg mice (TgCRND8) exhibiting familial Alzheimer’s disease-
associated variant of the amyloidprecursor protein and control non-Tg littermates show no 
change in Sho levels. (E) Normalized brain homogenates in a second cohort of 
RMLinoculatedmice show reduced Sho expression versus control mice injected with a brain 
homogenate from healthy mice (C57BL6 background, 154 days post inoculation). (This figure 
was taken from Watts et al., 2007) 
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targeted delivery of the lentivirus (Passet et al., 2012). Transcriptomic analysis highlighted 
synergetic and convergent roles of PrP and Sho at these early developmental stages. These 
data could suggest that Sho is the hypothesized π protein. 
The knockdown of Sprn suggested that the prion protein family members play a crucial role in 
mouse embryogenesis during the developmental window E7.5 – E11 (Young et al., 2009). 
Although expression of different members of the prion gene family has been reported during 
mouse embryogenesis, these studies either focused on later developmental stages (Miele et 
al., 2003) and/or were indirect, using reporter transgenes (Tremblay et al., 2007, Young et al., 
2011). Furthermore, very little information, if any, describes the developmental regulation of 
Prnd during mouse embryogenesis. 
The first aim of my study was to further study the expression pattern of the prion protein gene 
family in the early stages of mouse embryonic development which remains poorly describe, 
especially for Sho and Doppel (Watts et al., 2007, Young et al., 2011). Such data could 
provide information on whether or not these genes have redundant function during embryonic 
development.  
The second aim of my work was to study a specific mouse transgenic line LS1.06. Mouse 
from this line expresses a shRNA targeting Sprn. On FVB/N adult mice; it results in a 70% 
down-regulation of the brain level of expression of the Sprn gene (Young et al., 2009 and 
unpublished data). It was observed that this transgene was difficult to transmit to FVB/N PrP
-
/-
 mice. Origin of these difficulties was further assessed to determine if it could be associated 
with an embryonic lethal phenotype.  
 
MATERIALS AND METHODS 
Classical molecular biology manipulations, such as plasmid and genomic DNA purifications, 
restriction enzyme digestions, agarose gel electrophoresis were done according to Maniatis et 
al., 1982. In this section, we will only mention experiments that involved using specific kits 
or adapted procedures.  
I. Histological analysis-  
Collected mouse FVB/N embryos at 7.5 days post coitum (dpc) alongside their deciduas and 
uterine tissue were fixed in 4% PFA, dehydrated in ethanol before being embedded in paraffin 
and 5µm sections cut on a microtome.  Sections were stained by hematoxylin, eosin, and 
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saffron then photographed using the Nanozoomer (Hamamatsu). On average, 50 sections per 
embryos were made and analyzed.    
II. Expression analysis of the prion gene family at early embryonic stages  
II.I RT-PCR analyses : 
Reverse transcriptions were performed on total RNAs extracted from pools of embryos and/or 
of placenta tissues, using the SuperScript First-Stand Synthesis System for RT-PCR 
(InVitrogen, Cat.11904-018) according to the manufacturer’s instructions. For the reverse-
transcription reaction, either the random hexamers or specific primers (SprnR1 for Sprn and 
PrndR1 for Prnd) were used. Around 5 μg of total RNA were used per reaction.PCR analyses 
were performed on 2 μl of RT reactions. Unless specified, PCR were performed using the 
GoTaq Flexi DNA polymerase kit (Promega, M8306), following the manufacturer’s 
instructions. PCR were made in a volume of 100 μl, using 2 μl of purified genomic DNA (~20 
ng) or of RT reaction mixture. The reaction conditions were as follows: 40 cycles with 30s 
denaturation step at 92°C, 30s hybridization step at 60°C and 30s elongation step at 72°C. 
Following a final elongation step of 2 min at 72°C, the PCR reactions were stored at 4°C 
before analysis of a sample by agarose gel electrophoresis. Nested PCR were made similarly 
using 2 μl of the first PCR reaction as template.  
II.II In Situ Hybridization 
a. Synthesis of riboprobes:  
Mouse Prnd, Sprn and Prnp cDNA ORF (Open Reading Frame) were PCR-amplified from 
mouse genomic DNA. The gel purified DNA fragments (using GenEluto Agarose Spin 
Columns (Sigma 56500-70 EA)) were cloned in the pGEM-T vector (Figure 4), using the 
corresponding cloning kit (Promega, A1360). After electro-transformation of E. Coli DH5, 
recombinant plasmid containing colonies were selected and identified by plating the bacteria 
suspension into ampicillin, IPTG and X-Gal agarose plates, as described in Maniatis et al., 
1982. Recombinant plasmid DNAs were amplified and their inserts sequenced. It allowed to 
confirm the identity of the amplified cDNAs and to orientate the insert in the vector.  Using 
the restriction sites present in the vector at the edges of the insert, the recombinant plasmids 
were linearized. According to the restriction site used and to the orientation of the insert, it 
then allowed to synthesize a sense or an antisense probe using the Sp6 or T7 polymerases, 
recognition sites of with are present in the pGEM-T vector (figure 4 derived from Promega) 
[15] 
 
 
Figure 4.pGEM-T vector map used to clone Mouse Prnd, Sprn and Prnp cDNA from gel 
purified DNA fragments. 
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Riboprobe synthesis was performed as follows: 
The following reagents were 13 µl H2O, 2 µl of 10x transcription buffer (roche,10810274001 
or fermentas EP0113), 1 µl of 0.2 M DTT, 2 µlof 10x DIG RNA Labeling Mixture (Roche, 
11277073910), 1 µlof linearised plasmid (1µg), 0.5 µlof RNase Inhibitor (20u, Roche, 
3335399001) and1 µlof either SP6 (20u, Roche,10810274001) orT7 RNA Polymerase 
(200u,Fermentas, EP0113) were mixed in an eppendorf tube  at room temperature. The tube 
was incubated 2h at 37°C and 1 µl aliquot was removed and ran on an 1% agarose gel to  
estimatethe amount of RNA synthesized. An RNA band ~10-fold more intense than the 
plasmid band indicates that ~10 µg of probe had been synthesized. Then, 2 µl of DNase I 
(40u, Turbo Dnase, Life technologies, AM2238) was added to the mix and the tube incubated  
at 37°C for 15 min. The RNA probe was then ethanol-precipitated, collected by 
centrifugation, air dried and resuspended in 100 µl TE and stored at -20C. 
b. In situ Hybridization: 
The protocol adapted from David Wilkinson, 1999 was used. Only a summary of it is given 
below.  
The embryos were collected at 7.5, 8.5 and 9.5 dpc, dissected in (Phosphate Buffer Saline) 
PBS and fixed in 4% para-formaldehyde in PBS at 4°C overnight. Later they were washed 
twice in PBT (PBS+.1% Tween 20) at 4°C followed by washings with 25%, 50%, 75% 
Methyl alcohol (MeOH) in PBT and then twice with 100% MeOH. Embryos could be kept at 
-20°C in this solution. 
DAY 1 
Embryos are rehydrated by several washings in PBT solutions, treated with 6% hydrogen 
peroxide, proteinase K and prehybridized in the presence of yeast RNA. Then the 
prehybridization solution is replaced by the hybridization buffer in the presence of the heat-
denaturated riboprobe and the samples incubated at 70°C overnight.   
DAY 2 
Post-hybridization washes were performed and binding of the Anti- Dig- AP antibody was 
allowed to occur overnight at 4°C in TBST (Tris buffered saline+ Tween 20) in the presence 
of sheep serum.   
DAY 3 
[17] 
 
Several washes were performed to remove the excess of the antibody. 
DAY 4 
Antibody detection was performed using BM purple (Roche, 11442074001). Following 
washes with PBT, the embryos pictures were taken. Afterwards they were stored in 4% 
Paraformaldehyde. 
III. Analysis of the LSI.06 transgenic line 
 
III.I Transmission rate on Prnp
-/-
 genetic backgrounds: 
Genotyping of offspring from FVB/N LSI.06
+/-
-Prnp
+/-
crossed with Prnp
-/-
, FVB/N LSI.06
+/-
-
Prnp
+/-
 with C57/129/Sv Prnp
-/-
and from FVB/N LSI.06
+/-
-Prnp
-/-
 mice with FVB/N Prnp
-/-
 
mice was carried out using primers 5A and 3B for LSI 06 while mPrP A and mPrP B for 
Prnplocus (Table 1). 
 
III.II Cloning of the LSI.06 transgene integration site: 
The general strategy used is shown in figure 5. It is based on the use of a 6 bp-cutter 
restriction enzyme known to cut once near the 5’ or 3’ end of the integrated transgene. In the 
first step, genomic DNA from several (2 in our case) transgenic mice and from non-transgenic 
control animals are digested to completion with the chosen restriction enzyme. The second 
step involved a circularization of the obtained linearized fragments by ligation. Then two 
consecutive PCRs, including a nested second PCR, are performed using set of primers located 
within the transgene sequence in order to amplify the surrounding mouse genomic DNA 
(steps 3 and 4). In these PCRs, the elongation time is of 5 min in order to potentially amplify 
fragments of several kbp. A DNA fragment was then specifically amplified from the 
transgenic genomic DNA. This DNA is then gel purified using GenEluto Agarose Spin 
Columns (Sigma 56500-70 EA), sequenced and analyzed (step 5). 
RESULTS AND DISCUSSION 
I. Histological analysis of E7.5 embryos 
Comparative histological analyses of E7.5 embryos between FVB/N Prnp
-/-
 and FVB/N Prnp
-
/-
 embryos injected at the zygotic stage with either a FG12 lentiviral solution, used as a control 
as it only encodes GFP (http://www.addgene.org/14884), or an shRNA targeting Sprn LS2-
lentiviral solution (Young et al., 2009) were already performed (Passet et al., 2012). 
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Figure 5.Strategy of Cloning Transgene integration site 
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To summarize this study, in vitro manipulation of the eggs induced a developmental delay. 
Furthermore, LS2-injected embryos were characterized by reduced and even disorganized 
ectoplacental cones, with a notably reduced invasive trophoblast cell layer. 
The aim of this part of my study was to complete this observation by similarly analyzing 
FVB/N mouse embryos.  
The comparative analysis was done between mouse 7.5 dpc FVB/N embryos, in which PrP, 
Sho and Doppel are expressed normally, and FVB/N Prnp
-/-
 embryos at the same 
developmental stage. The development and size of the embryos were similar for both 
genotypes. The ectoplacental cones were also comparable in size and development. However, 
a region of hemorrhagic foci located just in front of ectoplacental cone was evidenced in all 
the FVB/N embryos (5/5). This lesion was never detected in any of the 6 analyzed FVB/N  
Prnp
-/-
embryos (Figure 6 and data not shown). 
PrP was suggested to be involved in various biological processes like cell migration and 
death, protease inhibition transcriptomic analysis of early mouse embryos (Khalifé et al., 
2011). Such biological functions might explain the observed phenotype. However, the number 
of embryos analyzed remains relatively low and further experiments would be needed to 
sustain this preliminary observation. 
 
II. Expression analysis of the prion gene family at early embryonic stages 
To assess the expression of Prnp, Prnd and Sprn during the developmental window that 
appeared important in Young et al., 2009 both in the embryonic body and the extra-embryonic 
tissue since this latter compartment is suspected to be responsible of the lethal phenotype in 
Prnp
-/-
, Sprn
-/-
knockdown embryos. The RNASeq analyses performed in the above-mentioned 
study also revealed that the three genes were expressed in E6.5 and E7.5 FVB/N embryos and 
that the knockout of Prnp did not apparently affect the observed low expression of Prnd and 
Sprn at these developmental stages (Passet et al., 2012, and unpublished observations). We 
thus focused on later developmental stages. Two complementary approaches were used, RT-
PCR and In Situ Hybridization (HIS).    
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Figure 6.Histological section of FVB/N WT embryos (a,b,c& d) at  7.5 dpc. The arrows show 
area of hemorrhagic foci in front of ectoplacental cone. e andf are FVB/N Prnp
-/-
embryo 7.5 
dpc( Taken from Passet et al., 2012,). The development, size and ectoplacental cones of 
embryos of both the genetic backgrounds are similar, but no hemorrhagic foci in Prnp
-/-
 
embryos is observed. 
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II.I RT-PCR analyses 
 
Total RNAs were isolated from pooled of 4 to 6 i) E8 total embryos, ii) dissected E10.5 and 
E13.5 trophectoderms and iii) embryonic bodies from FVB/N and FVB/N Prnp
-/-
 mice. At 
each developmental stage, two different pools were analyzed.  
Randon-primed RT-PCR experiments were performed using PrnpF/PrnpR , ActbF/ActbR, 
PrndF1/PrndR1, PrndF2/PrndR2, SprnF1/SprnR1, SprnF2/SprnR2 sets of primers (Table 1). 
All primer sets were chosen so that both primers are located on two different exons to avoid 
amplification of potential genomic DNA that could have contaminated the RNA preparations. 
Actb primers target the β-actin cDNA, detection of which was used for i) validation of the RT 
step and ii) internal normalization of the RT amount. The results obtained for Prnp and Actb 
indicated that both genes are expressed in the three developmental stages, both in the placenta 
(or trophectoderm) and in the embryonic compartment of FVB/N mice (Figure 7). As 
expected, no Prnp-expression signal could be detected in Prnp
-/-
 samples (Figure 7). No or 
very faint and non-reproducible signals were obtained when expression of Prnd and Sprn 
were similarly assessed. We could exclude the non-recognition of the targeted cDNAs by the 
oligonucleotides since they were successfully used in RT samples derived from adult tissues 
known to express Sprn and Prnd (data not shown). Thus, these results could suggest either 
that i) these genes were not expressed at these developmental stages or ii) they were expressed 
at much lower levels compared to Prnp and Actb. This latter hypothesis was indirectly 
sustained by the RNASeq data obtained at E6.5 and E7.5 that indicated a 100 or more fold 
difference between the expression levels of Prnp and Actb and that of Prnd or Sprn (Passet et 
al., 2012 and unpublished results). 
 
To further assess Prnd and Sprn expressions, we performed i) nested PCR using 
PrndF2/PrndR2 and SprnF2/SprnR2 sets of primers on PrndF1/PrndR1, SprnF2/SprnR2 RT-
PCR, respectively and ii) RT experiments using PrndR1 and SprnR1 oligonucleotides 
followed by PCR using PrndF2/PrndR2 and SprnF2/SprnR2 sets of primers. Again, nested 
PCR gave inconsistent results for the detection of Sprn expression, while it allowed that of 
Prnd in all analyzed samples but E8 (data not shown). Specific RT experiments allowed 
detecting the expression of both genes in placentas and embryos at E10.5 and E13.5 of 
FVB/N and FVB/N Prnp
-/-
 mice (Figure 7). Only very faint signals could be observed at E8. 
These results are consistent with i) expression of these genes during the assessed 
developmental stages, both in the embryonic body and extra-embryonic tissues and ii) a much  
[22] 
 
LS1-EcoR1: F1 GGCAGGGATATTCACCATTATC 
LS1-EcoR1: R1 GCTAGAGATTTTCCACACTGACTA 
  LS1-EcoR1: F2 CTTGGGTAGTTTGCAGTTTTAAAAT 
LS1-EcoR1: R2 ATCTCTAGTTACCAGAGTCACACA 
  LS1-EcoR1: F2' CTTGTGGAAAGGACGAAACACC 
LS1-EcoR1: R2' AGAGCTCCCAGGCTCAGATCTGGT 
  PrnpF CAACCGAGCTGAAGCATTCTG 
PrnpR GGACATCAGTCCACATAGTC 
  PrndF1 TCCAAGCTTCAGAGGCCACAGTA 
PrndR1 AGCTACCCGAGCTTCGGTGATCT 
PrndF2 CCACAGTAGCAGAGAACCGA 
PrndR2 TTCGGTGATCTGGCCGCCGCT 
  SprnF1 CAGTCGTGAGCTCTGCCTAA 
SprnR1 GCCTTACGCGTACTCAAGATG 
SprnF2 CACGGCCCCTAAATCGCTCA 
SprnR2 GGAACAGCTGTCACAGAGGA 
  ActbF GCTGTATTCCCCTCCATCGTG 
ActbR CACGGTTGGCCTTAGGGTTCAG 
 
Table 1.Sequence of Primers used for RT PCR and Genotyping of LS1 06 
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a.Expression analysis Prnp b.Expression analysis Actb
M  E° E    M  P   P° E   E° M  P° E° P   E
8jpc             10.5 jpc 13.5 jpc
M  E° E   M  P   P° E   E° M  P° E° P   E
8jpc             10.5 jpc 13.5 jpc
c.Expression analysis Sprn
M  E° E    M   P    P° E   E° M  P° E° P   E
8jpc             10.5 jpc 13.5 jpc
d.Expression analysis Prnd
M  E° E    M  P   P° E   E° M  P° E° P   E
8jpc             10.5 jpc 13.5 jpc
100bp
100bp100bp
100bp
200bp
200bp200bp
200bp
300bp 300bp
300bp300bp
M: 1kb plus DNA ladder (InVitrogen)
P: Placenta FVB/N
E: Embryo FVB/N
P°: Placenta FVB/N Prnp0/0
E°: Embryo FVB/N Prnp0/0
 
Figure7.Prion protein family gene expression in developing embryos:RT-PCR analysis. 
8,10.5 & 13.5 dpc are embryo stages. a, b, c, and d show the expression analysis of Prnp, 
Actb, Sprn and Prnd  respectively. (a& b)Random-primed RT-PCR experiment for expression 
analysis of Prnp and Actb show both genes are expressed in the three developmental stages 
and in both the placenta and embryo of FVB/N WT mice. (a) No expression of Prnp in Prnp
-/-
 
mice.(c& d) Specific RT experiments for expression analysis of Sprn and Prnd show 
expression of both genes in placentas and embryos at E10.5 and E13.5 of FVB/N and FVB/N 
Prnp
-/-
 mice. 
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level in the embryonic body (Figure 7). This observation could reflect either a lower 
transcriptional activation and/or an expression restricted to specific cellular lineages, as 
suggested by the data recently published on Sprn-LacZ transgenic mice at E13.5 (Young et 
al.,2011). HIS experiments were performed in parallel to further assess this point and to 
define more accurately potential overlapping expressing profiles of these three genes.     
 
II.II In Situ Hybridization 
In situ hybridization using anti sense probe was carried out for Sprn, Prnp and Prnd at 
embryo stages 7.5 (a), 8.5(b), 9.5(c) and 11.5(d) dpc while the same was carried out for Prnd 
using sense strand as negative control in mouse embryo stages 8.5(e) and 9.5(f) dpc (Figure 
8). 
Hybridization reaction signals in the form of blue stain were observed throughout the embryo 
and also in the ectoplacenta in each of the embryonic stage and for each of the gene when 
antisense probe was used (except for E8.5/b of Prnp, that gave poor signals for technical 
reasons. All the other embryos regardless of their developmental stage showed poor signals in 
that particular round of HIS. Since it was the only intact embryo obtained after 3 rounds of 
HIS, we decided to include it in the results). For Prnd, when the sense probe was used at E8.5 
and E9.5 no hybridization or signal were detected.  
This indicates that all the three genes are expressed in mouse embryos from E7.5 to E11.5 and 
their expression appears ubiquitous, although some embryonic regions could be seen as less 
labeled such as the heart. These results are in accordance with the results shown by RT PCR 
analysis and demonstrate the potential overlapping expression of these genes. More precise 
locations of the genes’ expression could perhaps be achieved on histological examination of 
sections of these embryos on which HIS has been performed. Such experiments are currently 
performed. 
Our data thus suggest that the expression of Sprn, Prnp and Prnd is ubiquitous. 
However,Young et al, (2009)reported expression of Sprn in 10.5–14.5 dpc embryos to be 
more restricted to specific embryonic and extra-embryonic cell lineages. This might be due to 
the fact they used an Sprn-LacZ transgene. Such a transgene might have a more restricted 
expression pattern compared to the endogenous gene, at least at these early developmental 
stages and/or its level of expression might only allow detection of the LacZ in cells that 
express Sprn at high levels. 
[25] 
 
Sprn 
 
Prnp 
 
Prnd 
 
Figure 8.In situ Hybridization on FVB/N WT embryos for Sprn, Prnp and Prnd expression 
analysis.(a-d) Embryo stages 7.5, 8.5, 9.5 and 11.5 dpc respectively for each of the protein; 
HIS is carried out using antisense probe show ubiquitous hybridization and signal. (e&f) 
Embryo stages 8.5 and 9.5 dpc; HIS is carried out using sense probe for Prnd expression 
show no hybridization or signal.(The size of all embryos was similar within the stages but 
varied between the stages). 
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Alternatively, it is also possible that some of the observed signals in our HIS experiments 
correspond to false signals. The results obtained with the sense Prnd probe make this 
hypothesis less likely. Immuno-histochemical analyses of embryos at these developmental 
stages would be interesting to perform to help clarifying this uncertainty. 
 
III. Further analysis of the LSI.06 transgenic line 
LSI-06 is a mouse transgenic line established on an FVB/N genetic background. It contains a 
single integration site encompassing a lentivirus-based insert that expresses a ShRNA 
targeting the mouse Sprn transcript (Young et al., 2009). In the adult brain, the level of 
expression of the Sprn gene was found to be down-regulated by 60 to 70% in LSI-06 
transgenic mice, at the RNA level. We wanted to assess the potential phenotypic impact of 
such a down-regulation in an FVB/N Prnp
-/-
 genetic background. 
III.I Transmission rate on Prnp
-/-
 genetic backgrounds 
 
LSI.06
+/-
-Prnp
+/+
 mice were crossed with FVB/N Prnp
-/-
 animals. Genotyping was done using 
primers 5A and 3B for LSI 06 while mPrP A and mPrP B for Prnplocus (Table 1). Fifty 
percent of their progeny were found to be LSI.06
+/-
-Prnp
+/-
, as expected (data not shown). 
These mice were again crossed with FVB/N Prnp
-/-
 mice. The observed transmission rate did 
not statistically follow a Mendelian ratio, as judged by X2 analysis (Table 2 and data not 
shown). 
Indeed, less than 5% of the offspring were of an FVB/N LSI.06
+/-
-Prnp
-/-
 genotype instead of 
the 25% expected. The percentage of FVB/N LSI.06
-/-
-Prnp
+/-
 was close from the expected 
ratio, although also slightly lower, 16%.  We first suspected an embryonic lethality in the 
FVB/N LSI.06
+/-
-Prnp
-/-
 associated with an incomplete penetrating phenotype.  We thus 
analysed i) the potential incidence of the genetic background associated with the Prnp null 
allele and ii) the secondary transmission rate of the LSI.O6 transgene on an FVB/N Prnp
-/-
 
environment. For the first point, LSI.06
+/-
-Prnp
+/-
 mice were crossed with C57/129/Sv Prnp
-/-
 
animals (Table 3). The obtained results indicated a non-Mendelian transmission rate with this 
time a clear deficiency in both the LSI.06
+/-
-Prnp
-/-
 and LSI.06
-/-
-Prnp
+/- 
genotypes. 
Analysis of the transmission rate of the LSI.O6 transgene on an FVB/N Prnp
-/-
 was made by 
crossing FVB/N LSI.06
+/-
-Prnp
-/-
 mice with FVB/N Prnp
-/-
 mice. Out of the 38 offspring 
obtained, 19 (50%) were found to be of an FVB/N LSI.06
+/-
-Prnp
-/-
 genotype. It suggested  
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Table 2:Analysis of FVB/N LSI.06
+/-
-Prnp
+/-
 X Prnp
-/-
 crossing. 
 
Genotype of offspring from 
FVB/N LSI.06
+/-
-Prnp
+/-
 X 
C57/129/Sv Prnp
-/-
 
Prnp
+/-
 Prnp
-/-
 
LSI.06
+/-
 20 1 
LSI.06
-/-
 3 18 
 
 
Table 3: Analysis of FVB/N LSI.06
+/-
-Prnp
+/-
 X C57/129 Prnp
-/-
 crossing. 
 
 
 
Genotype of offspring from 
FVB/N LSI.06
+/-
-Prnp
+/-
 X 
Prnp
-/-
 
Prnp
+/-
 Prnp
-/-
 
LSI.06
+/-
 29 3 
LSI.06
-/-
 10 19 
[28] 
 
 
Figure 9.Amplification of the LS1.06 transgene integration site. Using EcoR1 a specific band 
is generated from the transgenic genomic DNA samples following Nested PCR. 1kb: DNA 
ladder (GeneRuler, InVitrogen). 
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that once established on an FVB/N Prnp
-/-
 genetic background, the LSI.06 transgene was 
transmitted at a normal rate.  
Altogether, these transmission analyses of the LSI.06 transgene favored a physical link 
between its integration site and the Prnp locus rather than a lethal-associated embryonic  
 phenotype on a Prnp-knockout genetic background. To further assess this new hypothesis, 
we decided to clone its integration site.  
 
III.II Cloning of the LSI.06 transgene integration site 
The general strategy for cloning the LSI.06 integration site has been described in Figure 5. It 
is based on the use of a restriction enzyme that should cut within the transgene. Two such 
restriction sites were used BamHI and EcoRI. With BamHI, we could not isolate specific 
bands generated only from the transgenic mouse genomic DNA (data not shown). It is 
possible that no BamHI site exists in the mouse genomic DNA at sufficiently short distance 
from the LSI.06 integration site to allow efficient PCR amplification. We did not re-assed this 
point. Using EcoR1, following nested-PCR with either LSI-EcoRIF2/R2 or LSI-
EcoRIF2’/R2’ set of primers (Table 1), a specific band was generated from the transgenic 
genomic DNA samples (Figure 9). This DNA fragment was gel-purified and sequenced. Its 
sequence was than aligned, using the NCBI Blast software 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi), against the mouse genome and against the transgene 
backbone sequence (http://www.addgene.org/8453/sequences/#addgene_seq). As expected, 
part of the sequence (78 bp) was 100% identical with the edge of the vector backbone (Figure 
10). Most of the remaining of the sequence (600 bp) was 99% (599/600) homologous with a 
unique mouse genomic sequence located on mouse chromosome 2 within the transcription 
unit of the apoptosis inhibitor 5 gene. More precisely, the transgene appears to be integrated 
within the last known intron of the Api5 gene. This Api5 gene seems to be expressed at early 
mouse developmental stages according to recorded data 
(http://www.ncbi.nlm.nih.gov/sites/geo), and is thus a potential target for lentivirus that are 
known to favor integration in active transcription units (Ciuffi et al., 2008). 
The Prnp locus is also located onto mouse chromosome 2 (Figure 1) and the distance between 
the LSI.06 integration site and this gene appears to be of 37.5 Mb. Thus, this physical distance 
could explain the observed non-Mendelian transmission rate of the LSI.06 transgene. The 
genetic distance between the two loci, LSI.06 and Prnp, is of 17 cM, according to Table 1 and 
2, and is thus probably underestimated according to the observed physical distance.  
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Figure 10.Blast of the cloned LS1-integration site sequence against mouse genomic DNA 
 
> ref|NT_039207.8|  Mus musculus strain C57BL/6J chromosome 2 genomic contig, GRCm38  
C57BL/6J MMCHR2_CTG5 
Length=116378660 
 
 
 Features in this part of subject sequence: 
apoptosis inhibitor 5 
 
 Score = 1101 bits (596),  Expect = 0.0 
 Identities = 599/600 (99%), Gaps = 1/600 (0%) 
 Strand=Plus/Minus 
 
Query  147       TGAATTCCTCTGACCTTTGACAGTGGTCAAATCCCTTTTGACCAGACAGGTTGGAAAAAG  206 
                 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  35296502  TGAATTCCTCTGACCTTTGACAGTGGTCAAATCCCTTTTGACCAGACAGGTTGGAAAAAG  35296443 
 
Query  207       CCAGTTTTAGACTGAGAAATGAACCCTCCCATATAAATGAGCTCTTACAGCCTTCTTTAA  266 
                 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  35296442  CCAGTTTTAGACTGAGAAATGAACCCTCCCATATAAATGAGCTCTTACAGCCTTCTTTAA  35296383 
 
Query  267       GGAGTGCACCGAATCTTGGTACTCATATAACTGCATATACATGTGCATATGCACATTTGC  326 
                 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  35296382  GGAGTGCACCGAATCTTGGTACTCATATAACTGCATATACATGTGCATATGCACATTTGC  35296323 
 
Query  327       TTATGTGAAAAATAGGGATAGCAGAGTTCTTAGGAACTTAGGTAAGAATGGTTTTGAGAG  386 
                 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  35296322  TTATGTGAAAAATAGGGATAGCAGAGTTCTTAGGAACTTAGGTAAGAATGGTTTTGAGAG  35296263 
 
Query  387       GATTTGGTAATGAAAAGCAGTCTTTGTTGTTTTATTACATCAAATACTATCTTCTGATAT  446 
                 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  35296262  GATTTGGTAATGAAAAGCAGTCTTTGTTGTTTTATTACATCAAATACTATCTTCTGATAT  35296203 
 
Query  447       TTTTTGACTTAATGTGATATCTGTAAAATCTGAAAATCAGCAGTTAGATGCTATGAGGAA  506 
                 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  35296202  TTTTTGACTTAATGTGATATCTGTAAAATCTGAAAATCAGCAGTTAGATGCTATGAGGAA  35296143 
 
Query  507       ATAGCATGAACGAAAGTAATCATGATATTTTGCACAGCACATAAAGAAATGTATTTCTCT  566 
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  35296142  ATAGCATGAACGAAAGTAATCATGATATTTTGCACAGCACATAAAGAAATGTATTTCTCT  35296083 
 
Query  567       GTAACTTGAATAGTTACATGGTGAGTATGAGTTTCGAAACATAAAGATTTTGTCTCACAG  626 
                 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  35296082  GTAACTTGAATAGTTACATGGTGAGTATGAGTTTCGAAACATAAAGATTTTGTCTCACAG  35296023 
 
Query  627       AACCCACAGCTTGATATAAGGTGGAGAACAAATGCAGAAAATGTAACACATAGTTTGTAT  686 
                 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  35296022  AACCCACAGCTTGATATAAGGTGGAGAACAAATGCAGAAAATGTAACACATAGTTTGTAT  35295963 
 
Query  687       GCCAGTAAACTAGGATGTAAATATATTTTAATTTTAAA-GCTGCAAAAAAAAAAAAAAAA  745 
                 |||||||||||||||||||||||||||||||||||||| ||||||||||||||||||||| 
Sbjct  35295962  GCCAGTAAACTAGGATGTAAATATATTTTAATTTTAAAAGCTGCAAAAAAAAAAAAAAAA  35295903 
 
Alignment with the pLKO.1-puro vector sequence 
(vector: http://www.addgene.org/8453/sequences/#addgene_seq) 
 
>lcl|40691  
Length=7032 
 
 Score =  147 bits (79),  Expect = 4e-38 
 Identities = 79/79 (100%), Gaps = 0/79 (0%) 
 Strand=Plus/Plus 
 
Query  15    ACTATCATATGCTTACCGTAACTTGAAAGTATTTCGATTTCTTGGCTTTATATATCTTGT  74 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  6742  ACTATCATATGCTTACCGTAACTTGAAAGTATTTCGATTTCTTGGCTTTATATATCTTGT  6801 
 
Query  75    GGAAAGGACGAAACACCGG  93 
             ||||||||||||||||||| 
Sbjct  6802  GGAAAGGACGAAACACCGG  6820 
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Location of the Prnp exon 1 on mouse chromosome 2 
 
 
 Score =  143 bits (77),  Expect = 1e-30 
 Identities = 77/77 (100%), Gaps = 0/77 (0%) 
 Strand=Plus/Plus 
 
Query  1         CCCCTTTCCACTCCCGGCTCCCCCGCGTTGTCGGATCAGCAGACCGATTCTGGGCGCTGC  60 
                 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  72789287  CCCCTTTCCACTCCCGGCTCCCCCGCGTTGTCGGATCAGCAGACCGATTCTGGGCGCTGC  72789346 
 
Query  61        GTCGCATCGGTGGCAGG  77 
                 ||||||||||||||||| 
Sbjct  72789347  GTCGCATCGGTGGCAGG  72789363 
 
 
Deduced major features : 
- The integration site of LS1 is located within the last intron of the ORF of the mouse 
Api5 (apoptosis inhibitor 5) gene 
- The LS1 integration site is located at 37.5 Mb (37.493.025 nt) of the Prnp locus:  
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CONCLUSIONS 
 
Histological examination demonstrated that the phenotype of 7.5 dpc FVB/N mouse embryos 
is similar to that of FVB/N Prnp
-/-
at the same stage except for the observation of hemorrhagic 
foci just in front of ectoplacental cone in FVB/N WT embryos. By increasing the number of 
samples analyzed perhaps we can validate this phenotype and associate it with involvement of 
PrP
C
 in biological pathways such as angiogenesis, inflammation, cell mobility and 
gastrulation. Besides this, it could be interesting to compare FVB/N mouse embryos which 
have been down regulated for only Sprn with FVB/N and FVB/N Prnp
-/-
embryos to ascertain 
if these findings are consistent with potential overlapping roles of Sho and PrP and/or  
biological redundancy.  
To analyze the expression the prion gene family RT-PCR and In Situ Hybridization were 
carried out. RT PCR analysis was done on E8 total embryos, dissected E10.5 and E13.5 
trophoectoderms and embryonic bodies from FVB/N and FVB/N Prnp
-/-
 mice. We observed 
expression of Prnp in all the developmental stages and in both the placenta and embryo 
except in Prnp
-/-
, while we found low expression pattern of Prnd and Sprn.  
In situ hybridization of FVB/N WT embryos at 7.5 to 11.5 dpc for the 3 genes using antisense 
probes confirmed the expression of these genes in all the stages. Both the experiments thus 
could be considered as another clue suggesting overlapping expression profiles of these genes 
at early embryonic stages. The obtained results are thus compatible with biological 
overlapping roles of these proteins. 
The difficulty to introgress LSI 06 on Prnp null mice was demonstrated likely to be due to the 
physical linkage between the transgene and Prnp locus rather than an embryonic lethality. 
This would suggest that 70 % down regulation is not enough to induce lethality in Prnp null 
background (if at all it exists). Also an assessment of the fecundity of such mice, including 
growth rate and robustness of pups might give us a possible clue for what are the further 
effects of such introgression. 
However, the recent publication of the knockout of Sprn with no embryonic lethality 
associated in a Prnp knockout genetic background (Daude et al., 2012) appears to question 
the data obtained with the RNA interfering approach (Young et al., 2009, Passet et al., 2012). 
Several hypotheses could explain this apparent discrepancy; i) the use of a similar but not 
identical genetic background, ii) a specific susceptibility of the double-knockout embryos to 
lentiviral infection and iii) an off-target effect of the ShRNAs. This latter hypothesis is 
unlikely as two different shRNAs were used and the off-targeted locus (or loci) would have to 
[33] 
 
induce lethality only in the absence of PrP. The use of ZFN will allow to inactivate Sprn in 
the precise genetic background used in Young et al., 2009 and such experiments are currently 
underway.    
Our results also point out a potential role of Doppel in early embryonic stages. Although the 
double knockout of Prnp and Prnd has been reported and gave a phenotype similar to that of 
the single Prnd invalidation, it would be of interest to assess the phenotypic consequences of 
the invalidation of Sprn and Prnd, and of the three loci. Again, such experiments are currently 
performed using a ZFN approach. 
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